3-(Trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 5g

4-Nitro-2-thiophenecarboxylic acid, 95.0%, 1g

4-(6-Dimethylamino-4-trifluoromethyl-pyridin-2-yl)-benzaldehyde, 95.0%, 500mg

4-Cyclohexylpyridine, 95%, 250mg

Ethyl 6-[(2-Cyanoethoxy)(4,4-diphenylcyclohexyloxy)phosphoryloxy]hexanoate>95.0%(HPLC)500mg

Bi polvo 99,99% -100, +325 malla 250 g

4-Chloro-2-(1-pyrrolidino)-5-thiazolecarboxaldehyde, 95.0%, 5g

1-(4-Aminophenyl)-4-(4-hydroxyphenyl)piperazine, 95.0%, 100g

(3-Amino-piperidin-1-yl)-acetic acid methyl ester dihydrochloride, 97%, 1g

2-Methylbenzhydryl Chloride>98.0%(GC)(T)5g

N,N'-Bis(2-phenylethyl)ethanediamide, 95+%, 1g

Portaobjetos de diagnóstico PTFE 100 uds.

Tris(2-(3-tert-butylphenyl)pyridine)iridium, 98%, 50mg